Reference publications: Abetz L, Coombs JH, Keininger DL, Earle CC, Wade C, Bury-Maynard D,Copley-Merriman K, Hsu MA. Development of the cancer therapy satisfaction questionnaire: item generation and content validity testing. Value Health. 2005 Nov-Dec;8 Suppl 1:S41-53.
Trask PC, Tellefsen C, Espindle D, Getter C, & Hsu M-A. Psychometric validation of the Cancer Therapy Satisfaction Questionnaire (CTSQ). Value in Health. 2008 Jul-Aug;11(4):669-79. Epub 2008 Jan 8
Conditions of use:
1. User Agreement:
Existing translations: user is required to complete and sign a User Agreement with Pfizer Inc. in which specific conditions required by Pfizer Inc. are detailed.
New translation(s): in addition to the User Agreement, user is required to complete and sign a Translation Agreement with Pfizer Inc.
2. Access Fees:
Distribution fees are requested according to the study design and context of use of the questionnaire:
- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 300 €* per study + 50 €* per language version
- In commercial studies (3) involving "for-profit" organizations: 700 €* per study + 250 €* per language version
* excluding VAT
(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.
(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.
(3) Commercial studies (industry, CRO, any for-profit companies).
27 rue de la Villette F - 69003 LYON Tel: +33 4 72 13 65 75 Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Please have two original copies of the User Agreement and/or Translation Agreement completed, dated and signed and return them both to MAPI Research Trust by post. As soon as we receive them, we will process your request.